Daria Donati

Daria Donati serves as the Chief Scientific Officer for Genomic Medicines at Cytiva, where responsibilities include leading mergers and acquisitions and driving global strategic partnerships focused on innovative technologies in the life sciences sector. Prior experience includes board membership at the Vaccines Manufacturing and Innovation Centre (VMIC UK) and advisory roles with Financial Times and GE Healthcare, where Daria led business development and innovation efforts in life sciences and bioprocess sectors. Daria's background encompasses research leadership roles at institutions such as the Karolinska Institute and organizational contributions to global initiatives on malaria, alongside extensive educational credentials including dual PhDs in Experimental Medicine and Immunology, as well as business training from Harvard Business School.